Dr. Ashok Srivastava

Dr. Ashok Srivastava, MD, Ph.D., MBA

Global Leader in Oncology Drug Development & Commercialization

A distinguished physician-executive and visionary leader with over 15 years of experience pioneering the development, commercialization, and safety of novel cancer therapies worldwide. Dr. Srivastava has led large, complex global clinical trials and successfully brought transformative medicines to market, generating significant revenue and improving patient outcomes across the globe.

Back to Team Contact AyurDatta

Professional Leadership

  • Chief Medical Officer, AyurDatta Solutions, Trans Atlantic Therapeutics (Oncology)
  • Former Chief Medical Officer, CareBeyond — A Radiation Therapy Cancer Center, New Jersey, USA
  • Strategic Medical Advisor & Board Member to numerous pharmaceutical companies in the USA, UK, and India

Key Areas of Expertise

  • Global Oncology Drug Development (Phase I–IV)
  • Medical Affairs & Drug Commercialization
  • Regulatory Strategy (INDs, NDAs) — US, EU, Japan
  • Pharmacovigilance & Drug Safety
  • Business Development & Asset Acquisition
  • Hematology, Radiopharmaceuticals & Immuno-Oncology

Career Highlights & Impact

Program leadership
Pioneered development programs including Sutent (Sunitinib), liposomal doxorubicin (Myocet), and Evoxac.
Regulatory submissions
Instrumental in 21 IND submissions and 7 NDAs for oncology therapies.
Business impact
Spearheaded the acquisition and merger of a company and drug asset valued at over $300M.
Market success
Brought two cancer drugs and a vaccine to global markets with combined sales of approximately $3–3.5B.
Innovation
Recognized as one of the inventors of the Japanese encephalitis vaccine (IXIARO).
Safety & PV
Built global drug safety and pharmacovigilance organizations in the USA and India.

Board & Advisory Roles

  • Board of Advisors, Calidi Biotherapeutics (San Diego, CA)
  • Scientific Board Member, Carcinotech (UK)
  • Co-Founder, rTrTechnovation (CA)
  • Medical Advisor, Autolus (London, UK)
  • Board Member, multiple oncology-focused virtual pharma companies (USA)

Education & Global Training

  • Clinical & Medical Education: All India Institute of Medical Sciences (AIIMS, New Delhi); Academy of Medical Sciences (Czechoslovakia); Nagasaki University School of Medicine (Japan).
  • Pharmaceutical Business Management: Rutgers University, New Jersey, USA.
  • Professional Tenures: Walter Reed Army Institute of Research; Pfizer; Pharmacia; Eisai Oncology; Daiichi; Spectrum Pharmaceuticals.

Awards, Recognition & Scholarship

  • Recipient of awards from the United Nations, Ministry of Health (Japan), and the U.S. Department of the Army.
  • Named among America's Top Oncologists (2007, 2008, 2011).
  • Member, Japan External Trade Organization (JETRO), USA.
  • Author of 85+ publications, 120+ abstracts, 3 book chapters, and holder of 2 patents.
  • Invited speaker at international congresses in London, China, India, and Washington, D.C.

Professional Affiliations

  • American Society of Clinical Oncology (ASCO)
  • American Association for Cancer Research (AACR)
  • American Society for Therapeutic Radiology & Oncology (ASTRO)
  • International Society of Lung Cancer
  • Indian Society of Oncology
  • Breast Cancer Foundation